Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.550
+0.110 (2.48%)
At close: Nov 3, 2026, 4:00 PM EST
4.580
+0.030 (0.66%)
Pre-market: Nov 4, 2026, 4:05 AM EST

Prime Medicine Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4.074.632.98---
Revenue Growth
-17.90%55.28%----
Gross Profit
-142.13-156-152.31-147.91-86.73-70.55
Operating Income
-196.52-208.35-202.47-191.29-116.54-84.47
Net Income
-187.89-201.14-195.88-198.13-142.01-184.12
Earnings Per Share
-1.09-1.35-1.65-2.18-4.19-14.19
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
95.07177.68190.44121.67293.92269.62
Total Debt
112.48116.4340.7913.6328.7510.41
Net Cash (Debt)
-17.4161.25149.65108.03265.18259.21
Net Cash Growth
--59.07%38.52%-59.26%2.30%623.80%
Net Cash Per Share
-0.100.411.261.197.8219.98

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-156.05-162.56-122.87-165.41-131.83-34.08
Capital Expenditures
-0.8-4.53-7.29-8.72-16.1-4.15
Free Cash Flow
-156.85-167.1-130.16-174.14-147.92-38.23
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-4824.95%-4498.06%-6787.36%---
Pretax Margin
-4613.11%-4342.44%-6566.61%---
Profit Margin
-4613.11%-4342.44%-6566.61%---
FCF Margin
-3850.92%-3607.40%-4363.36%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
198.74132.63124.90---